Copyright
©The Author(s) 2023.
World J Hepatol. May 27, 2023; 15(5): 585-608
Published online May 27, 2023. doi: 10.4254/wjh.v15.i5.585
Published online May 27, 2023. doi: 10.4254/wjh.v15.i5.585
Figure 1 Hepatitis B virus life cycle and the effects of current and novel therapies.
CpAMs: Core protein assembly modulators; cccDNA: Covalently closed circular DNA; DSL-DNA: Double stranded linear DNA; ER: Endoplasmic reticulum; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; HBV: Hepatitis B virus; IFN: Interferon; NAs: Nucleos(t)ides analogues; pgRNA: Pre-genomic RNA; rcDNA: Relaxed circular DNA.
- Citation: Salama II, Sami SM, Salama SI, Abdel-Latif GA, Shaaban FA, Fouad WA, Abdelmohsen AM, Raslan HM. Current and novel modalities for management of chronic hepatitis B infection. World J Hepatol 2023; 15(5): 585-608
- URL: https://www.wjgnet.com/1948-5182/full/v15/i5/585.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i5.585